Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Osteosarcoma × Ifosfamide × Clear all

Phase

Phase 2 13 Phase 1/2 4 Phase 1 4 Phase NA 3 Phase 3 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Synovial 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Perivascular Epithelioid Cell Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neurofibrosarcoma 1 Nerve Sheath Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Histiocytoma, Angiomatoid Fibrous 1 Granuloma, Plasma Cell 1 Fibrosarcoma 1 Fallopian Tube Neoplasms 1 Dermatofibrosarcoma 1 Chondrosarcoma, Mesenchymal 1 Chondrosarcoma, Extraskeletal Myxoid 1 Carcinoma, Ovarian Epithelial 1

Interventions

Doxorubicin 2 apatinib 1 Zoledronic Acid 1 Triptorelin Pamoate 1 Methotrexate 1 Ifosfamide 1 Drug Therapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00691236 2011-06-23

ZOL

Tata Memorial Hospital

Phase 2/3 Unknown

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡